CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total	Series B Preferred Stock	Preferred Stock	Common Stock	Treasury Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings	Retained Earnings Series B Preferred Stock
Beginning balance, shares issued (in shares) at Dec. 31, 2021			2,510,696	432,013,372
Beginning balance (in shares) at Dec. 31, 2021					(153,056,639)
Beginning balance (in shares) at Dec. 31, 2021				278,956,733
Beginning balance at Dec. 31, 2021	$ 2,149,711		$ 251,070	$ 86,403	$ (2,061,383)	$ 1,074,384	$ (17,897)	$ 2,817,134
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	469,014							469,014
Other comprehensive income (loss), net of tax	(75,973)						(75,973)
Total comprehensive income	393,041
Cash dividends declared:
Common stock	$ (112,961)							(112,961)
Preferred stock		$ (9,029)							$ (9,029)
Issuance of common shares (in shares)	3,107,768			3,107,768
Issuance of common shares	$ 433			$ 622		618		(807)
Stock-based compensation expense	$ 34,359					34,070		289
Common stock repurchased (in shares)	(40,253,548)			(40,253,548)	(40,253,548)
Common stock repurchased	$ (707,742)				$ (707,742)
Shares repurchased related to employee stock-based compensation plans (in shares)	(1,135,509)			(1,135,509)	(1,135,509)
Shares repurchased related to employee stock-based compensation plans	$ (20,842)				$ (20,842)
Ending balance, shares issued (in shares) at Dec. 31, 2022			2,510,696	435,121,140
Ending balance (in shares) at Dec. 31, 2022					(194,445,696)
Ending balance (in shares) at Dec. 31, 2022				240,675,444
Ending balance at Dec. 31, 2022	1,726,970		$ 251,070	$ 87,025	$ (2,789,967)	1,109,072	(93,870)	3,163,640
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	581,391							581,391
Other comprehensive income (loss), net of tax	18,766						18,766
Total comprehensive income	600,157
Cash dividends declared:
Common stock	$ (101,233)							(101,233)
Preferred stock		(17,705)							(17,705)
Issuance of common shares (in shares)	3,109,276			3,109,276
Issuance of common shares	$ 2,625			$ 622		3,237		(1,234)
Stock-based compensation expense	$ 36,380					36,380
Common stock repurchased (in shares)	(22,341,595)			(22,341,595)	(22,341,595)
Common stock repurchased	$ (349,397)				$ (349,397)
Shares repurchased related to employee stock-based compensation plans (in shares)	(1,099,241)			(1,099,241)	(1,099,241)
Shares repurchased related to employee stock-based compensation plans	$ (17,000)				$ (17,000)
Ending balance, shares issued (in shares) at Dec. 31, 2023			2,510,696	438,230,416
Ending balance (in shares) at Dec. 31, 2023	(217,900,000)				(217,886,532)
Ending balance (in shares) at Dec. 31, 2023				220,343,884
Ending balance at Dec. 31, 2023	$ 1,880,797		$ 251,070	$ 87,647	$ (3,156,364)	1,148,689	(75,104)	3,624,859
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	608,325							608,325
Other comprehensive income (loss), net of tax	9,243						9,243
Total comprehensive income	617,568
Cash dividends declared:
Common stock	$ (99,172)							(99,172)
Preferred stock		$ (18,296)							$ (18,296)
Issuance of common shares (in shares)	2,374,379			2,374,379
Issuance of common shares	$ 4,272			$ 474		5,068		(1,270)
Stock-based compensation expense	$ 39,996					39,996		0
Common stock repurchased (in shares)	(11,586,103)			(11,586,103)	(11,586,103)
Common stock repurchased	$ (250,108)				$ (250,108)
Shares repurchased related to employee stock-based compensation plans (in shares)	(749,866)			(749,866)	(749,866)
Shares repurchased related to employee stock-based compensation plans	$ (15,137)				$ (15,137)
Ending balance, shares issued (in shares) at Dec. 31, 2024			2,510,696	440,604,795
Ending balance (in shares) at Dec. 31, 2024	(230,200,000)				(230,222,501)
Ending balance (in shares) at Dec. 31, 2024				210,382,294
Ending balance at Dec. 31, 2024	$ 2,159,920		$ 251,070	$ 88,121	$ (3,421,609)	$ 1,193,753	$ (65,861)	$ 4,114,446